glp-1 therapy for diabetes GLP-1-based therapies type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome GLP-1 Agonists: A Comprehensive Overview
Description
Willow does not publish a clinician roster, clinician credentials list, or a public medication menu before intake gating is cleared
All data are expressed as mean SEM
A recent study raises questions about whether GLP-1 drugs like Ozempic and Mounjaro actually increase thyroid cancer risks, indicating that previously suggested associations may be the result of more intensive screening, rather than side effects the drugs have on the body
Greenway, L
References Biondi B, Wartofsky L
Changes in physical activity patterns during treatment may also play a role
